Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jeffrey

Showing results (551-560 of 651) with videos related to

Pageof 66
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 27, 2011
Development of a more highly selective M(1) antagonist from the continued optimization of the MLPCN Probe ML012Bruce J Melancon, Alexander P Lamers, Thomas M Bridges, et al.
Hepatology International|July 13, 2011
Comparison of noninvasive models of fibrosis in chronic hepatitis BS C Raftopoulos, J George, M Bourliere, et al.
Molecular Pharmacology|October 25, 2011
Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system functionMeredith J Noetzel, Jerri M Rook, Paige N Vinson, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
Novel 1,2,3,4-tetrahydroisoquinolines with high affinity and selectivity for the dopamine D3 receptorN E Austin, K Y Avenell, I Boyfield, et al.
Hepatology (Baltimore, Md.)|August 12, 2009
Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressureAndri Rauch, Ian James, Katja Pfafferott, et al.
ACS Chemical Neuroscience|August 8, 2018
Discovery of Tricyclic Triazolo- and Imidazopyridine Lactams as M<sub>1</sub> Positive Allosteric ModulatorsJulie L Engers, Aaron M Bender, Jacob J Kalbfleisch, et al.
ACS Chemical Neuroscience|September 13, 2016
Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M<sub>1</sub> PAM VU6004256Michael D Grannan, Catharine A Mielnik, Sean P Moran, et al.
Journal of Medicinal Chemistry|November 3, 2015
Design of 4-Oxo-1-aryl-1,4-dihydroquinoline-3-carboxamides as Selective Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 2Andrew S Felts, Alice L Rodriguez, Katrina A Smith, et al.
Journal of Medicinal Chemistry|November 13, 2004
Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H- pyrazol-5-yl)benzamides that potentiate receptor function in vivoCraig W Lindsley, David D Wisnoski, William H Leister, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Development of a novel, CNS-penetrant, metabotropic glutamate receptor 3 (mGlu3) NAM probe (ML289) derived from a closely related mGlu5 PAMDouglas J Sheffler, Cody J Wenthur, Joshua A Bruner, et al.
Pageof 66

Showing results (551-560 of 651) with videos related to

Sort By:
Pageof 66
Bioorganic & Medicinal Chemistry Letters|December 27, 2011
Development of a more highly selective M(1) antagonist from the continued optimization of the MLPCN Probe ML012Bruce J Melancon, Alexander P Lamers, Thomas M Bridges, et al.
Hepatology International|July 13, 2011
Comparison of noninvasive models of fibrosis in chronic hepatitis BS C Raftopoulos, J George, M Bourliere, et al.
Molecular Pharmacology|October 25, 2011
Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system functionMeredith J Noetzel, Jerri M Rook, Paige N Vinson, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
Novel 1,2,3,4-tetrahydroisoquinolines with high affinity and selectivity for the dopamine D3 receptorN E Austin, K Y Avenell, I Boyfield, et al.
Hepatology (Baltimore, Md.)|August 12, 2009
Divergent adaptation of hepatitis C virus genotypes 1 and 3 to human leukocyte antigen-restricted immune pressureAndri Rauch, Ian James, Katja Pfafferott, et al.
ACS Chemical Neuroscience|August 8, 2018
Discovery of Tricyclic Triazolo- and Imidazopyridine Lactams as M<sub>1</sub> Positive Allosteric ModulatorsJulie L Engers, Aaron M Bender, Jacob J Kalbfleisch, et al.
ACS Chemical Neuroscience|September 13, 2016
Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M<sub>1</sub> PAM VU6004256Michael D Grannan, Catharine A Mielnik, Sean P Moran, et al.
Journal of Medicinal Chemistry|November 3, 2015
Design of 4-Oxo-1-aryl-1,4-dihydroquinoline-3-carboxamides as Selective Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 2Andrew S Felts, Alice L Rodriguez, Katrina A Smith, et al.
Journal of Medicinal Chemistry|November 13, 2004
Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H- pyrazol-5-yl)benzamides that potentiate receptor function in vivoCraig W Lindsley, David D Wisnoski, William H Leister, et al.
Bioorganic & Medicinal Chemistry Letters|May 22, 2012
Development of a novel, CNS-penetrant, metabotropic glutamate receptor 3 (mGlu3) NAM probe (ML289) derived from a closely related mGlu5 PAMDouglas J Sheffler, Cody J Wenthur, Joshua A Bruner, et al.
Pageof 66